In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Who are you? What’s going on deep inside yourself? How do you understand your own mind? The ancient sages had big debates about this, and now modern neuroscience is helping us sort it all out. When my ...

Shares of Recursion Pharmaceuticals (NASDAQ:RXRX) traded higher in the premarket on Tuesday after the AI-driven biotech announced plans to reduce its workforce by approximately 20% as part of a ...

Before you can change an ACL, you must get the current one. There are two ways to do this with PowerShell. Learn how to get the current ACL and modify it.

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. How do I know I can trust these reviews about DentalWorks? How do I know I can trust these ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...